Literature DB >> 8092273

Electrophysiological-anatomic correlates of ATP-triggered vagal reflex in dogs. II. Vagal afferent traffic.

C M Hurt1, L Wang, J Xu, W Sterious, A Pelleg.   

Abstract

Extracellular ATP can act on chemosensitive vagal C-fiber nerve terminals in the lungs, thereby eliciting a pulmonary-cardiac depressor reflex. Previous studies have shown a right vagal dominance in afferent traffic elicited by intra-right atrial ATP. To elucidate the mechanism of this phenomenon, the following hypotheses were tested in a canine model. 1) Intra-right and intra-left pulmonary ATP elicit neural afferent traffic, which travels via the right and left vagus nerves, respectively. 2) Intra-right vs. intra-left pulmonary ATP causes similar suppression of sinus node automaticity. Data obtained in this study support both hypotheses and suggest that right vagal dominance in afferent neural traffic elicited by ATP is probably due to the action of ATP and/or its metabolites on nonpulmonary tissues.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8092273     DOI: 10.1152/ajpheart.1994.267.3.H1093

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  4 in total

1.  A new function for ATP: activating cardiac sympathetic afferents during myocardial ischemia.

Authors:  Liang-Wu Fu; John C Longhurst
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-24       Impact factor: 4.733

2.  Mechanism of action of ATP on canine pulmonary vagal C fibre nerve terminals.

Authors:  A Pelleg; C M Hurt
Journal:  J Physiol       Date:  1996-01-01       Impact factor: 5.182

3.  Activation of P2X receptors for adenosine triphosphate evokes cardiorespiratory reflexes in anaesthetized rats.

Authors:  D S McQueen; S M Bond; C Moores; I Chessell; P P Humphrey; E Dowd
Journal:  J Physiol       Date:  1998-03-15       Impact factor: 5.182

Review 4.  The therapeutic promise of ATP antagonism at P2X3 receptors in respiratory and urological disorders.

Authors:  Anthony P Ford; Bradley J Undem
Journal:  Front Cell Neurosci       Date:  2013-12-19       Impact factor: 5.505

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.